Aquestive Therapeutics, Inc. Increase (Decrease) in Prepaid Expense
Aquestive Therapeutics, Inc. (AQST) reported Increase (Decrease) in Prepaid Expense of $416.00 thousand for the 6-month period ending 2019-06-30, per its 10-Q filed 2019-08-06.
Discontinued › Cash Flow › Operating Activities
us-gaap:IncreaseDecreaseInPrepaidExpense · last filed 2019-08-06
- Aquestive Therapeutics, Inc. increase (decrease) in prepaid expense for the quarter ending 2019-06-30 was -$1.30M, a 1114.84% decline year-over-year.
- Aquestive Therapeutics, Inc. increase (decrease) in prepaid expense for the quarter ending 2019-03-31 was $1.72M, a 3262.75% increase year-over-year.
- Aquestive Therapeutics, Inc. increase (decrease) in prepaid expense for the quarter ending 2018-06-30 was $128.00K.
- Aquestive Therapeutics, Inc. increase (decrease) in prepaid expense for the quarter ending 2018-03-31 was $51.00K.
- Aquestive Therapeutics, Inc. increase (decrease) in prepaid expense for fiscal 2018 was $1.14M, a 566.67% increase from fiscal 2017.
- Aquestive Therapeutics, Inc. increase (decrease) in prepaid expense for fiscal 2017 was $171.00K.
| Period end | Increase (Decrease) in Prepaid Expense 3 month | Increase (Decrease) in Prepaid Expense 6 month | Increase (Decrease) in Prepaid Expense 12 month |
|---|---|---|---|
| 2019-06-30 | -$1.30M derived: 10-Q 6 month − 10-Q 3 month · filed 2019-08-06 | $416.00K 10-Q · filed 2019-08-06 | |
| 2019-03-31 | $1.72M 10-Q · filed 2019-05-08 | ||
| 2018-12-31 | $1.14M 10-K · filed 2019-03-14 | ||
| 2018-06-30 | $128.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2019-08-06 | $179.00K 10-Q · filed 2019-08-06 | |
| 2018-03-31 | $51.00K 10-Q · filed 2019-05-08 | ||
| 2017-12-31 | $171.00K 10-K · filed 2019-03-14 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| CorMedix Inc. (CRMD) | United States | $0.605B | 3.25 |
| IMPACT BIOMEDICAL INC. (IBO) | United States | $0.611B | 66.47 |
| CytomX Therapeutics, Inc. (CTMX) | United States | $0.598B | -10.25 |
| Monopar Therapeutics (MNPR) | United States | $0.598B | -34.82 |
| Altimmune, Inc. (ALT) | United States | $0.593B | -6.43 |
| Neurogene Inc. (NGNE) | $0.625B | -4.46 | |
| Shattuck Labs, Inc. (STTK) | United States | $0.634B | -13.30 |
| Phathom Pharmaceuticals, Inc. (PHAT) | United States | $0.572B | -8.76 |
| BlossomHill Therapeutics, Inc. (BLSM) | United States | $0.647B | |
| ZEVRA THERAPEUTICS, INC. (ZVRA) | United States | $0.668B | 14.61 |